In this episode, we hear from Dr. Jeffrey Morgan, M.D. and Chief Medical Officer at BIOLIFE4D. BIOLIFE4D is a biotech company dedicated to the development of a bioartificial heart, which would improve safety and accessibility of heart transplantation. Currently, the number of people who need heart transplants far outweighs the amount of available donor organs, but with the development of bioartificial hearts, this will be a problem of the past. It gets better- by using the heart recipients own cells, the risk of the body rejecting the organ is eliminated. Listen in to hear Dr. Morgan share more about developments at BIOLIFE4D and learn other important applications of bioartificial hearts.
Learn more at https://biolife4d.com. Dr. Morgan also encourages you to check out related press releases and interviews on social media sites such as YouTube and Facebook.